Top Clinical Trials companies in Hong Kong by Capital Expenditure
Hong Kong
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -32.61 M
|
Dec. 31, 2023 | USD 2.68 | -1.44% |
|
Hong Kong |
|
| 2 |
USD -21.15 M
|
Dec. 31, 2023 | USD 0.22 | -1.18% |
|
Hong Kong |
|
| 3 |
USD -20.45 M
|
Dec. 31, 2023 | USD 0.16 | -3.21% |
|
Hong Kong |
|
| 4 |
USD -14.63 M
|
Dec. 31, 2023 | USD 0.13 | -0.02% |
|
Hong Kong |
|
| 5 |
USD -1.74 M
|
Dec. 31, 2023 | USD 0.37 | 4.31% |
|
Hong Kong |
|
| 6 |
USD -911.81 K
|
Dec. 31, 2023 | USD 5.25 | -2.96% |
|
Hong Kong |
|
| 7 |
USD -5.38 K
|
June 30, 2024 | USD 3.80 | 0.53% |
|
Hong Kong |
Frequently Asked Questions
-
Which Clinical Trials company in Hong Kong has the highest Capital Expenditure ?
The Clinical Trials company in Hong Kong with the highest Capital Expenditure is HUTCHMED (China) Limited (HKSE: 0013.HK) at USD -32.61 M.
-
Which Clinical Trials company in Hong Kong has the lowest Capital Expenditure ?
The Clinical Trials company in Hong Kong with the lowest Capital Expenditure is Regencell Bioscience Holdings Limited (NasdaqCM: RGC) at USD -5.38 K.
-
What are the top 10 Clinical Trials companies in Hong Kong by Capital Expenditure ?
The top 10 Clinical Trials companies in Hong Kong by Capital Expenditure are HUTCHMED (China) Limited, Frontage Holdings Corporation, Lee's Pharmaceutical Holdings Limited, SinoMab BioScience Limited, Sirnaomics Ltd., Prenetics Global Limited and Regencell Bioscience Holdings Limited.
-
What are the bottom 10 Clinical Trials companies in Hong Kong by Capital Expenditure ?
The bottom 10 Clinical Trials companies in Hong Kong by Capital Expenditure are Regencell Bioscience Holdings Limited, Prenetics Global Limited, Sirnaomics Ltd., SinoMab BioScience Limited, Lee's Pharmaceutical Holdings Limited, Frontage Holdings Corporation and HUTCHMED (China) Limited.
